Yinlong Yang1,2, Shiping Li3,4, Guangyu Liu3,4, Zhiming Shao5,6. 1. Department of Breast Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200000, People's Republic of China. lancetyang@126.com. 2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200000, People's Republic of China. lancetyang@126.com. 3. Department of Breast Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200000, People's Republic of China. 4. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200000, People's Republic of China. 5. Department of Breast Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200000, People's Republic of China. zhimingshao@yahoo.com. 6. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200000, People's Republic of China. zhimingshao@yahoo.com.
Abstract
PURPOSE: The objective of this study was to examine the diagnostic accuracy of sonographically guided core needle biopsy (CNB) of breast lesions in men. METHODS: This was a retrospective study where we analyzed consecutive sonographically guided 14-gauge CNB results on 234 male breast lesions. The CNB accuracy is determined by the comparison between the CNB and its corresponding excisional biopsy or to long-term follow-up imaging. RESULTS: Sonographically guided CNB was effective to collect satisfactory samples from all 234 lesions. Out of those, 58.55% (137/234) were benign, 38.0% (89/234) were malignant, 1.71% (4/234) were papilloma with atypia and 1.71% (4/234) were atypical ductal hyperplasia lesions. Underestimation occurred in 3.4% (8/234) of the lesions. As for the detection of breast malignancy, the sensitivity of the CNB is 98.9%, specificity is 100%, negative predictive value is 99.3%, positive predictive value is 100%, false positive is 0% and false negative is 1.1%. The overall accuracy of sonographically guided CNB as a diagnostic tool is 99.6%. CONCLUSION: Sonographically guided 14-gauge CNB is an accurate, reliable and low invasive procedure for assessing breast lesions in men. Triple tests and follow-up checks of benign cases are essential for a successful breast biopsy program in men.
PURPOSE: The objective of this study was to examine the diagnostic accuracy of sonographically guided core needle biopsy (CNB) of breast lesions in men. METHODS: This was a retrospective study where we analyzed consecutive sonographically guided 14-gauge CNB results on 234 male breast lesions. The CNB accuracy is determined by the comparison between the CNB and its corresponding excisional biopsy or to long-term follow-up imaging. RESULTS: Sonographically guided CNB was effective to collect satisfactory samples from all 234 lesions. Out of those, 58.55% (137/234) were benign, 38.0% (89/234) were malignant, 1.71% (4/234) were papilloma with atypia and 1.71% (4/234) were atypical ductal hyperplasia lesions. Underestimation occurred in 3.4% (8/234) of the lesions. As for the detection of breast malignancy, the sensitivity of the CNB is 98.9%, specificity is 100%, negative predictive value is 99.3%, positive predictive value is 100%, false positive is 0% and false negative is 1.1%. The overall accuracy of sonographically guided CNB as a diagnostic tool is 99.6%. CONCLUSION: Sonographically guided 14-gauge CNB is an accurate, reliable and low invasive procedure for assessing breast lesions in men. Triple tests and follow-up checks of benign cases are essential for a successful breast biopsy program in men.
Entities:
Keywords:
Breast neoplasm; Breast ultrasonography; Core needle biopsy; Male breast cancer; Male lesions
Authors: I Meattini; G Bicchierai; C Saieva; D De Benedetto; I Desideri; C Becherini; D Abdulcadir; E Vanzi; C Boeri; S Gabbrielli; F Lucci; L Sanchez; D Casella; M Bernini; L Orzalesi; V Vezzosi; D Greto; M Mangoni; S Bianchi; L Livi; J Nori Journal: Eur J Surg Oncol Date: 2016-11-17 Impact factor: 4.424
Authors: Abdulkhaleq A Binnuhaid; Sultan Abdulwadoud Alshoabi; Fahad H Alhazmi; Tareef S Daqqaq; Suliman G Salih; Sami A Al-Dubai Journal: J Family Med Prim Care Date: 2019-12-10